Purple Pen Podcast

Join Kristin as she talks with Dr Mark Horowitz about how to deprescribe psychotropics like antidepressants, what is known about the causes of depression, what evidence is behind the antidepressants commonly used, what the symptoms of antidepressant withdrawal look like and the origins of the phrase "it's Bedlam here."

The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs are available for purchase here:

https://www.wiley.com/en-us/The+Maudsley+Deprescribing+Guidelines%3A+Antidepressants%2C+Benzodiazepines%2C+Gabapentinoids+and+Z+drugs-p-9781119823025

This podcast has been released to co-incide with MedsAware which is SHPA's Deprescribing Action Week, 18-24 March 2024 - find out more here:

https://www.shpa.org.au/news-advocacy/MedsAware

Have a listen as Kristin talks to Associate Professor Deshan Sebaratnam about psoriasis. Who does it typically affect, how is it managed and there can be a lot more to psoriasis than meets the eye.

Tune in as Kristin chats to Pia Nairn, Clinical Audiologist at Lions Hearing Clinic to discuss Tinnitus, general advice for looking after your hearing and what to expect in a hearing assessment

Check out a bumper episode of the Purple Pen Podcast with Specialist Cardiac Pharmacist and PhD candidate Adam Livori as well discuss what in, and definitely what's out when it comes to cholesterol management.

Adam is the Lead Pharmacist - Medical Specialties and Ambulatory Care at Grampians Health Services in Victoria and is the current Chair of the SHPA Cardiology Specialty Practice Leadership Committee. His PhD through Monash University is looking for patterns and predictors of clinical outcomes in myocardial infarction and atrial fibrillation.

Connect with Adam via LinkedIn

Join us as Kristin talks to Natalie Raffoul (a pharmacist who now works at the Heart Foundation) to discuss the new Aus CVD Risk calculator and associated guideline. They also talk about the highlights of the European Society of Cardiology (ESC) Congress in Amsterdam this year.

https://www.cvdcheck.org.au/overview

https://www.heartfoundation.org.au/heart-age-calculator

Natalie is joined by Dr Ian Bilmon, a senior consultant Haematologist working at Westmead Hospital and Sydney Adventist Hospital to do a deep dive into haemochromatosis. They cover:

• What is heriditary haemochromatosis or iron overload?

• How is haemochromatosis managed?

• What other conditions are patients with haemochromatosis at risk of?

• Who else is at risk of iron overload and how is it managed?

Avid Purple Pen listeners may recognise Dr Bilmon who has been on our podcast previously. Check out episode 70 where Ian goes back to Haematology Basics.

• the HPV vaccine
• genital warts
• cervical cancer
• changes to National Cervical Screening Program (pap smears)

Kristin and Nat were at the 81st FIP World Congress of Pharmacy and Pharmaceutical Sciences this week in Brisbane. They caught up with Professor Parisa Aslani, Paul Sinclair AM, Anna Packer, Dr Sami Isaac, Aagam Bordia, Dr Kaitlyn Watson, Dr Michael Stepanovic and Dr Stephen Eckel. Have a listen for a taste of what the congress had to offer.

Link to the Basel Statements - https://www.fip.org/basel-statements#:~:text=The%20Basel%20Statements%20cover%20all,practice%20through%20updating%20the%20statements.

Happy World Pharmacist Day 2023!

Kristin and Natalie are joined by Tom Simpson, Executive Director - Statewide Hospital Pharmacy, Tasmania and President of the Society of Hospital Pharmacists of Australia (SHPA) to discuss opportunities for Australian pharmacists in 2023 and beyond.

Celebrating our 150th episode with pharmacist Karl Winckel from Princess Alexandra Hospital in Brisbane, as Kristin and Nat ask Karl to dispel some myths about metformin.

Resources related to this episode:

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus (Review)

Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas

Risk of Fatal and Nonfatal Lactic Acidosis With Metformin Use in Type 2 Diabetes Mellitus

Chapter 12: Assessing Drug Safety Assessment: Metformin Associated Lactic Acidosis